InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$266.90

2026-10-16

Market Cap

$43.9B

Volume

1.0M

52-Wk High

$277.40

52-Wk Low

$154.50

Trailing PE

32.8

P/S

2.59

Gross Margin

26.2%

Net Margin

8.1%

ROE

22%

ROIC

8%

Piotroski

7/9

Altman Z

2.2

1-Yr Return

+29.8%

5-Yr Return

+72.5%

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

SectorHealthcareIndustryMedical - Diagnostics & ResearchExchangeNYSEMarket Cap$43.9BEmployees93,000 (SEC-filed)CEOAri BousbibIPO2013-05-09CountryUS

2400 Ellis Road, Durham, NC 27703 · Tel 919 998 2000 · iqvia.com

INSIDERSTREET SCORE56 / 100Street mean $294.56 (9 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$30M sold / 6 mo, zero open-market buys

1 Year vs S&P 500 · IQV +29.8% · S&P 500 +15.9% · spread +13.9pp

7 Years vs S&P 500 · IQV +72.5% · S&P 500 +189.9% · spread -117.4pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE56of 100

Score Breakdown

Profitability	45/100
Growth	55/100
Momentum	82/100
Quality	59/100
Earnings Quality	70/100
Balance Sheet	21/100
Value	41/100
Risk (safety)	50/100
Overall	56.4/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
IDXX	80
WAT	47
ILMN	58
A	71
NTRA	50
MTD	63
IQV	56

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 59 in 24 Q3, latest 56 — -3 since. Fell in 0 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY56 / 100IS Score 56.4 / 100 · -2.8 from peak of 59

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 82 / 100 · Power +64 · 20 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 56 and price structure at 82 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 56.4	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 51 → 51 → 53 → 56	the direction matters more than the level
Technical vote share back above 50%	now 73%	price structure no longer broken
Institutional holder count rises two quarters running	peak 1,139 → now 1,090	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score2 of 4top 13% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)0 buysnone disclosed

Insider Buys (180d)0none disclosed

ETF Funds (30d)1134 up / 1092 downnet +42 funds

Institutions Added (13F)23managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 1,139 · latest 1,090 (-49 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	1,090	158.2M	$30.3B	94.6%
2026 Q1	1,067	156.6M	$26.6B	93.7%
2025 Q4	1,139	160.9M	$35.9B	96.2%
2025 Q3	1,004	158.3M	$29.8B	94.7%
2025 Q2	975	161.9M	$25.1B	96.8%
2025 Q1	986	153.9M	$26.6B	92.1%
2024 Q4	996	153.5M	$29.4B	91.8%
2024 Q3	1,053	156.6M	$35.8B	93.7%
2024 Q2	1,011	157.4M	$32.2B	94.1%
2024 Q1	1,009	157.9M	$38.2B	94.4%
2023 Q4	954	161.1M	$35.7B	96.3%
2023 Q3	936	160.6M	$30.7B	96.1%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Berkshire James G.	See Remarks	2026-09-02	EXERCISE	5,381	$0.71M	13,558
Berkshire James G.	See Remarks	2026-09-02	SELL	2,668	$0.70M	10,890
Berkshire James G.	See Remarks	2026-09-02	D-Return	2,713	$0.71M	8,177
Berkshire James G.	See Remarks	2026-09-02	EXERCISE	5,381	$0.71M	0
Staub W Richard	See Remarks	2026-08-03	SELL	5,500	$1.28M	13,312
Patel Bhavik	See Remarks	2026-07-31	SELL	1,855	$0.44M	1,348
Sherbet Eric	See Remarks	2026-07-29	SELL	5,000	$1.25M	20,999
Cherofsky Keriann	See Remarks	2026-07-29	SELL	558	$0.14M	2,989

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	9	121,860	$29.9M	Counted
M — Exercises (paired A/D)	2	161,587	$12.9M	None — mechanics
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$29.9M9 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-08-03	Walter Staub	5,500	$1.3M
2026-07-31	Bhavik Patel	1,855	$0.4M
2026-07-29	Ari Bousbib	106,279	$26.1M
2026-07-29	Eric Sherbet	5,000	$1.2M
Trailing 12 mo	8 filings	216,313	$51M

Filed	Form	Reporting person	% of class	Shares
2026-04-30	SCHEDULE 13G	Vanguard Capital Management	7.49%	12.7M sh
2026-03-27	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change
2025-08-14	SCHEDULE 13G/A	Harris Associates, Inc.	6.80%	11.8M sh
2025-05-09	SCHEDULE 13G/A	GIC Private Ltd	3.71%	6.5M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Kevin Hern	House	SELL	$15,001 - $50,000	2026-09-14	2026-09-28
Kevin Hern	House	SELL	$15,001 - $50,000	2026-09-14	2026-09-25
Kevin Hern	House	SELL	$15,001 - $50,000	2026-09-14	2026-09-25
Markwayne Mullin	Senate	BUY	$15,001 - $50,000	2025-12-29	2026-01-16
Markwayne Mullin	Senate	BUY	$15,001 - $50,000	2025-12-29	2026-01-15
John Boozman	Senate	SELL	$1,001 - $15,000	2025-10-02	2025-11-15

House 12-Mo14 trades1 purchases

Senate 12-Mo6 trades2 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)1,067

13F Shares157M93.7% of shares out

New / Closed121 / 177positions, QoQ

Increased / Reduced414 / 402positions, QoQ

Put/Call (13F)1.13option positions

Free Float94.9%156M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Assenagon Asset Management S.A.	326,418	$88M
Artemis Investment Management Llp	297,972	$80M
Nichols & Pratt Advisers Llp /Ma	135,930	$35M
Vontobel Holding Ltd.	102,916	$28M
Congress Asset Management Co	91,352	$25M
Wealth Enhancement Advisory Servic	58,672	$14M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.1%	$1.4B
VTSAX	0.1%	$1.4B
VSMPX	0.1%	$1.4B
VTI	0.1%	$1.4B
VOO	0.1%	$1.2B
VFINX	0.1%	$1.2B

13F Filers Holding IQV — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session47.4%2026-10-15

20-Day Avg30.1%50-day 40.0%

TrendFalling20d vs 50d

By Market CenterQ: 47% · N: 57% · B: 72%latest session

Weekly Notional ($B)

Where IQV Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Sgmt Sigma X2	2.8M	40 sh
Mlix Instinct X	1.7M	61 sh
Ubsa Ubs Ats	1.7M	48 sh
Ebxl Level Ats	1.6M	34 sh
Mspl Ms Pool (Ats-4)	1.4M	155 sh
Cgxs Onechronos	1.4M	76 sh

Where a dollar of IQVIA Holdings Inc. revenue goes. All values FY2025 filings, live.

Region	Revenue	Share
Americas	$7.7B	47%
EMEA	$5.2B	32%
Asia Pacific	$3.4B	21%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

IQV (live moat model)Peer median: IDXX · WAT · ILMN · A · NTRA

Component scores from the live moat model. Peer median illustrative.

Moat score 48/100 — Weak; primary source Efficient Scale.

3.8 · Employees (SEC filings)

Officer	Title
Ari Bousbib	Chief Executive Officer & Chairman
Michael J. Fedock	Executive Vice President & Chief Financial Officer
W. Richard Staub	President of Research & Development Solutions
Alistair Grenfell	President of Commercial Solutions

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)3 of 6recent quarters

Avg Surprise+2.0%

Next Report2026-10-27

Income Quality2.04OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+22.1%	+3.9%	+4.0%	+2.8%	+5.9%
Gross profit	+20.3%	+8.3%	+4.2%	+2.6%	-20.3%
Operating income	+90.6%	+29.1%	+9.9%	+11.4%	+3.9%
Net income	+246.2%	+12.9%	+24.5%	+1.1%	-0.9%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	13.9	14.4	15.0	15.4	16.3
Cost of revenue	9.2	9.4	9.7	10.0	12.0
Gross profit	4.6	5.0	5.2	5.4	4.3
R&D expense	0.0	0.0	0.0	0.0	0.0
SG&A expense	2.0	2.1	2.1	2.0	2.0
Operating income	1.4	1.8	2.0	2.2	2.3
EBITDA	2.8	2.9	3.3	3.5	3.5
D&A	1.3	1.1	1.1	1.1	1.1
Pretax income	1.1	1.4	1.5	1.7	1.6
Income tax	0.2	0.3	0.1	0.3	0.3
Net income	1.0	1.1	1.4	1.4	1.4
Diluted EPS ($)	4.95	5.72	7.29	7.49	7.84
Diluted shares (M)	195	191	186	183	174

Operating CF$3B

CapEx$1B

Free cash flow$2B

SBC$0B

Buybacks$1B

Net cash change$0B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	1.2	1.4	1.7	2.0
ST investments	0.1	0.1	0.1	0.2
Receivables (net)	3.0	3.4	3.2	3.4
Total current assets	5.0	5.6	5.8	6.2
PP&E (net)	0.9	0.8	0.8	0.8
Goodwill + intangibles	18.7	19.4	19.2	21.6
Total assets	25.3	26.7	26.9	29.9
Accounts payable	0.6	0.7	0.7	3.8
Short-term debt	0.2	0.7	1.1	1.8
Deferred revenue	1.8	1.8	1.8	2.1
Total current liabilities	5.6	6.5	7.0	8.3
Long-term debt	12.6	13.0	12.8	14.1
Total liabilities	19.6	20.6	20.8	23.3
Shareholders' equity	5.8	6.1	6.1	6.6

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	1.1	1.4	1.4	1.4
D&A	1.1	1.1	1.1	1.1
Stock-based compensation	0.2	0.2	0.2	0.2
Working capital change	(0.1)	(0.3)	0.2	0.1
Operating cash flow	2.3	2.1	2.7	2.7
Capital expenditures	(0.7)	(0.6)	(0.6)	(0.6)
Investing cash flow	(2.0)	(1.6)	(1.4)	(2.3)
Buybacks	(1.2)	(1.0)	(1.4)	(1.2)
Dividends paid	0.0	0.0	0.0	0.0
Debt issuance / (repay)	0.9	0.8	0.6	1.2
Financing cash flow	(0.3)	(0.4)	(0.9)	(0.2)
Free cash flow	1.6	1.5	2.1	2.1

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	16.0%	18.5%	22.9%	22.5%	21.6%	22%
ROA	3.9%	4.4%	5.2%	5.1%	4.8%	4.6%
ROIC	7.1%	8.4%	9.9%	10.0%	9.4%	8.3%
Gross margin	33.5%	34.9%	35.0%	34.9%	26.3%	26.2%
Operating margin	10.0%	12.5%	13.2%	14.3%	14.0%	13.6%
Net margin	7.0%	7.6%	9.1%	8.9%	8.3%	8.1%
EBITDA margin	19.9%	20.2%	21.7%	22.4%	21.2%	20.8%
FCF margin	16.6%	11.0%	10.0%	13.7%	15.2%	—
VALUATION
P/E	56.90	35.42	31.40	25.88	28.49	32.8
P/B	9.10	6.70	6.98	5.86	5.96	7.2
P/S	3.96	2.68	2.85	2.31	2.38	2.59
P/FCF	23.88	24.36	28.43	16.81	15.62	16.8
EV/EBITDA	23.93	17.35	16.91	13.80	15.24	16.5
EV/Revenue	4.75	3.49	3.67	3.11	3.24	3.4
Earnings yield	1.8%	2.8%	3.2%	3.9%	3.5%	3.08%
FCF yield	4.2%	4.1%	3.5%	6.0%	6.4%	5.95%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	0.91	0.89	0.86	0.84	0.75	0.71
Quick ratio	0.91	0.89	0.86	0.84	0.75	0.71
Debt / equity	2.06	2.26	2.27	2.33	2.49	2.63
Debt / assets	50.4%	51.4%	52.1%	52.6%	54.0%	54.4%
Net debt / EBITDA	3.98	4.03	3.81	3.55	4.05	4.06
Interest coverage	3.98	4.26	3.17	3.51	3.18	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.56	0.58	0.58	0.58	0.57	0.57
Receivables turnover	5.59	5.27	4.76	4.68	4.94	5.0
DSO (days)	65	69	77	78	74	73
DPO (days)	24	24	25	26	68	105
Cash conversion cycle	42	45	51	52	6	-32
GROWTH (YoY)
Revenue growth	22.1%	4.0%	3.9%	2.8%	5.9%	—
Net income growth	246.2%	12.9%	24.5%	1.1%	-0.9%	—
EPS growth	240.0%	16.7%	27.4%	3.1%	4.2%	—
FCF growth	71.4%	-31.1%	-5.4%	40.9%	17.3%	—
PER SHARE ($)
EPS (diluted, TTM)	4.96	5.78	7.37	7.59	7.91	8.22
Book value / share	31.02	30.57	33.16	33.56	37.83	37.69
Revenue / share	71.21	76.46	81.30	85.20	94.88	101.57
FCF / share	11.82	8.41	8.14	11.69	14.43	15.63
Cash / share	7.58	6.94	8.12	10.19	12.45	12.44
SHAREHOLDER RETURN & SCORES
Buyback yield	0.7%	3.0%	2.3%	3.8%	0.5%	0.40%
Altman Z-Score	2.63	2.14	2.28	2.15	2.06	2.2
Piotroski F-Score	7	7	7	6	5	7/9
Beneish M-Score	-2.80	-2.59	-2.46	-2.71	-0.36	-2.69

Model	Score	Zone	Note
Piotroski F-Score	7 / 9	Strong
Altman Z-Score	2.2	Grey zone	Grey
Income quality	2.04	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.69	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.85
Interest burden	0.69
Operating margin	13.8%
Asset turnover	0.58×
Financial leverage	4.90×
= ROE	23%

Growth Quality (live)	Value
Revenue stability	0.98
Earnings stability	0.64
Earnings persistence	0.96
Revenue CAGR 3y	5.0%
EPS CAGR 3y	11.6%
FCF CAGR 3y	18.2%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield0.40%

Dividend Yield0.00%none paid

Total Shareholder Return0.07%cash yield

SBC / Revenue1.6%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
IDXX	$44.1B	39.4	74%	27.8%	+12.8%	9/9	-12.1%
WAT	$42.9B	108.7	2%	-8.3%	+52.5%	5/9	+30.5%
ILMN	$39.6B	48.5	32%	17.9%	+4.9%	7/9	+173.7%
A	$48.8B	34.0	21%	19.3%	+8.6%	7/9	+22.6%
NTRA	$56.7B	-289.3	-13%	-8.9%	+37.8%	6/9	—
MTD	$32.5B	36.4	-736%	22.7%	+6.9%	8/9	—
DGX	$25.9B	24.6	14%	10.5%	+9.9%	8/9	—
LH	$25.8B	26.1	12%	8.0%	+6.4%	8/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

45 Analysts

Str Sell (0)Sell (1)Hold (7)Buy (36)Str Buy (1)

Mean Target (qtr)$294.569 targets

Target vs. Price+10.4%last-quarter mean

Next Report2026-10-27street $3.25

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$17.41B	$17.48B / $17.39B	$12.94	$13.00 / $12.89	14
FY2027	$18.44B	$19.00B / $18.22B	$14.39	$15.05 / $13.94	14
FY2028	$19.55B	$20.71B / $19.19B	$16.15	$19.11 / $13.78	8

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$315.40	+18.2%	5
Last Quarter	$294.56	+10.4%	9
Last Year	$253.58	-5.0%	33
All Time	$253.42	-5.1%	68

Rolling mean of published targets vs. last close $266.90. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B+

DCF

4/5

ROE

5/5

ROA

4/5

Debt/Eq

1/5

P/E

2/5

P/B

2/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

IQV +29.8% vs S&P 500 +15.9% — spread +13.9pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$265.34	+1.56	+0.59%	Above
SMA 50	$260.02	+6.88	+2.65%	Above
SMA 200	$207.74	+59.16	+28.48%	Above
EMA 9	$264.31	+2.59	+0.98%	Above
EMA 21	$263.66	+3.24	+1.23%	Above
EMA 50	$254.96	+11.94	+4.68%	Above
EMA 200	$219.72	+47.18	+21.47%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTBULLISHPower Score +6420 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%100

Momentum 25%90

Volume 20%69

Volatility 10%83

Patterns 15%50

This Week73% bullishof 11 price-based votes

4 Weeks Ago100%-27 pts since

12 Weeks Ago64%+9 pts since

ReadStabilizingweek-over-week trajectory

Price vs SMA 20$265.34

Price vs SMA 50$260.02

Price vs SMA 200$207.74

EMA 9/21 Cross264.3/263.7

SMA 50/200Golden

ADX DirectionADX 22

Supertrend$252

Parabolic SAR$253

SMA Slope0.030

RSI54.9

Stochastic K/D65/52

StochRSI K/D64/45

Williams %R-33

CCI41

TSI vs Signal5.5

CMO9.8

ROC3.41%

OBV SignalAccum

Chaikin MF-0.030

MFI64

Force Index1M

Elder Ray Bull9.22

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 52

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$268.16 / $274.56 / $278.07	S1 / S2	$264.65 / $258.25
Bollinger (20,2)	$255.06 – $275.63	Squeeze	ON
52-wk range	$154.50 – $277.40	Off 52-wk high	-3.8%
ATR (14)	$7.38 (2.8%)	Historical vol	26.7%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+0.9%Jan69%

-0.2%Feb46%

-2.9%Mar46%

+1.9%Apr42%

+1.3%May69%

+3.6%Jun62%

+8.5%Jul92%

+0.1%Aug62%

-2.9%Sep31%

-0.3%Oct38%

+2.9%Nov62%

+1.5%Dec54%

Sample: 13 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	IQV	S&P 500
Weekly volatility (σ, 1y)	6.53%	1.83%
Best / worst week (1y)	+24.7% / -15.5%	—
Max drawdown (5y, monthly)	-47.4%	—
1-week VaR (95%)	-10.2%	—
Beta (5y)	1.19	1.00

IQV EQUITY WEATHER (LIVE)CLOUDY · +15

Trend+38

Momentum+23

Volume+26

Volatility-30

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 193 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall+14.7+31.8 vs industry

Trend+37.7+45.0 vs industry

Momentum+22.9+49.9 vs industry

Volume+25.9+25.9 vs industry

Reading	IQV	Medical - Diagnostics & Research n=227	Healthcare n=5,272	All US symbols n=70,435
Overall	+14.7	-17.0	-24.0	-20.5
Trend	+37.7	-7.2	-25.6	-21.3
Momentum	+22.9	-27.0	-28.5	-15.8
Volume	+25.9	+0.0	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Ari Bousbib Chairman and Chief Executive Off	$28.1M	74% equity+incentive
Ronald E. Bruehlman Executive Vice President	$11.4M	70% equity+incentive
Alistair R. Grenfell President, Commercial S	$9.7M	70% equity+incentive
W. Richard Staub, III President, Research &	$8.8M	70% equity+incentive
Alistair R. Grenfell President, Commercial S	$5.5M	68% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	65
Social	56
Governance	58
Composite ESG	60

Composite ESG Trend

Filed	8-K contents	Items
2026-09-23	Material Agreement; Financial Obligation; Exhibits	1.01,2.03,9.01
2026-09-09	Other Events; Exhibits	8.01,9.01
2026-07-28	Earnings Release; Exhibits	2.02,9.01
2026-06-11	Material Agreement; Financial Obligation; Exhibits	1.01,2.03,9.01
2026-06-04	Other Events; Exhibits	8.01,9.01
2026-06-03	Other Events; Exhibits	8.01,9.01
2026-05-07	Other Events; Exhibits	8.01,9.01
2026-05-05	Earnings Release; Exhibits	2.02,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-10-20 to 2026-07-28
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	40 rows · 2010 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-07-29 to 2026-09-02
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2025-05-09 to 2026-04-30
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

IQVIA Holdings Inc. (IQV)

Institutions holding — 12 quarters

IQVIA Holdings Inc. (IQV)

Monthly Net Insider Flow (000 shares)

Signal Summary

IQVIA Holdings Inc. (IQV)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding IQV — quarterly

Institutional Put/Call — quarterly

IQVIA Holdings Inc. (IQV)

Where IQV Trades in the Dark

IQVIA Holdings Inc. (IQV)

3.8 · Employees (SEC filings)

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

Balance Sheet — Full

Cash Flow Statement — Full

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

Street Price Target — Trajectory

Third-Party Composite Rating

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

Family Scores (site weights)

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. (IQV)